Hosted on MSN1mon
J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular TherapiesThe deal values Intra-Cellular at $14.6 billion ... Caplyta is a small molecule formulated as a capsule taken once daily. The way this drug works to treat neurological conditions is unknown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results